Fluid Phase Equilibria in biopharmaceutics is a critical field that investigates the complex interplay between drugs and biological systems, aiming to optimize drug delivery and enhance therapeutic outcomes. Understanding the equilibrium of fluids in biological environments is pivotal for designing pharmaceutical formulations that ensure effective drug absorption, distribution, metabolism, and excretion (ADME). This branch of study delves into the dynamic equilibrium between drug molecules, physiological fluids, and biological membranes.
Researchers in Fluid Phase Equilibria within Biopharmaceutics explore how factors like solubility, partition coefficients, and molecular interactions influence drug behavior within the human body. This knowledge is instrumental in tailoring drug formulations to improve bioavailability, reduce side effects, and achieve targeted delivery. The synergy of fluid phase equilibria and biopharmaceutics plays a crucial role in advancing drug development, providing insights that bridge the gap between pharmaceutical science and the intricacies of the human body.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia